This study evaluated whether methotrexate use increased the presence of liver fibrosis (scarring) in patients with rheumatoid arthritis (RA). The data showed that there was no increase in the rate of liver fibrosis in patients with RA that received methotrexate.

This study compared the safety and effectiveness of liraglutide (Victoza) to insulin glargine (Lantus) on glycemic (blood glucose) control in patients with type 2 diabetes (T2D) after hospital discharge. The authors concluded that liraglutide treatment led to improved glycemic control and greater weight loss compared to insulin glargine, after hospital discharge.

This study investigated the possible effects of Punica granatum (pomegranate) on indicators and symptoms caused by rheumatoid arthritis (RA).

The data showed that pomegranate may have a positive impact on RA-related indicators and symptoms.

This study looked at the use of omarigliptin (Marizev) in insulin-treated patients with uncontrolled type 2 diabetes (T2D). It found that omarigliptin was well-tolerated and improved blood glucose control. 

This review focused on the effect of sodium-glucose cotransporter-2 inhibitors (SGLT-2i) on heart failure hospitalization in patients with type 2 diabetes (T2D). This analysis showed that SGLT-2is may reduce the risk of heart failure hospitalizations in these patients.

This study looked at the effect of exercise on patients with diabetic retinopathy (DR). They found that patients who did a lot of exercise were less likely to need laser treatment for DR than patients who did a small amount of exercise.

This study compared two types of intravitreal injection for the treatment of diabetic macular edema (DME). It found that a course of bevacizumab (Avastin) injections resulted in a greater improvement in vision than a course of triamcinolone (Kenalog) injections.  

This study tested the ability of henagliflozin (SHR3824) in controlling blood glucose levels in patients with type 2 diabetes (T2D). The authors found that henagliflozin alone was able to control glucose levels, reduce body weight and blood pressure in these patients.

This review focused on the effects of curcumin on blood glucose and lipid (blood fat) levels in patients with uncomplicated type 2 diabetes (T2D). This analysis showed that curcumin has benefits for glucose metabolism and lipid functions in these patients.

This study examined the effects of intensive therapy on the occurrence of bone fractures in patients with type 2 diabetes (T2D). The data showed that there was no increased risk of fractures with an intensive multifactorial intervention in these patients.